Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-05-10-Speech-4-352-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-05-10"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"hu"^^xsd:language2
lpv:document identification number	"en.20120510.69.4-352-000"2
lpv:hasSubsequent	lp_eu:2012-05-10-Speech-4-352-1252
lpv:speaker	lp:Tamás Deutsch2
lpv:spokenAs	substitute; EMPL (2012-01-19--2014-06-30)3 unknown; Fidesz-Magyar Polgári Szövetség-Keresztény Demokrata Néppárt (2009-07-14--2014-06-30)3 member; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 substitute; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3 member; REGI (2012-01-19--2014-06-30)3 member; CONT (2012-01-19--2013-01-21)3 substitute; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Following the presentation of the European Court of Auditors’ annual report for the financial year 2010, the European Parliament’s Committee on Budgetary Control carried out the financial audit of the European Union general budget in respect of the Innovative Medicines Initiative Joint Undertaking as part of the 2010 discharge procedure. The Committee’s primary responsibility is to ensure and verify that the Community budget is implemented in a regular and efficient manner. As regards the Joint Undertaking’s financial management, the discharge report highlighted the fact that internal governance structures are not yet working optimally, that proactive communication activities are still lacking, and that available human resources capacities are not sufficiently exploited. It should be noted that the Joint Undertaking put several implementing measures in place in its operational processes in order to prevent conflicts of interest. All individuals involved in the activities of the Joint Undertaking should comply with pre-established rules. Furthermore, the discharge report calls on the Joint Undertaking to develop an action plan with concrete measures and deadlines to prevent conflicts of interest and strengthen transparency, and to submit it to the discharge authority. The discharge report notes that the financial audit was completed properly and revealed no major deficiencies regarding the Innovative Medicines Initiative. At its meeting in late March, the Committee decided to grant discharge and to close the accounts for 2010. I supported the granting of discharge at both the Committee vote and the vote in plenary."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph